On May 18, anhuailue, the shareholder of Xinbang Pharmaceutical (securities code: 002390), pledged 54.529 million shares to GF Securities Co., Ltd. for equity investment.
The pledged shares were 54.529 million, accounting for 41.71% of the company’s shares and 3.27% of the company’s total share capital. The pledge period is from May 17, 2021 to May 16, 2022.
According to the announcement, anhuilue held 130743878 shares of the company, accounting for 7.84% of the total share capital of the company. The total number of Pledged Shares is 54528970, accounting for 41.71% of its shares and 3.27% of the total share capital of the company.
According to the company’s report for the first quarter of 2021, the company’s net profit attributable to shareholders of Listed Companies in the first quarter of 2021 was 72181104.84 yuan, turning losses into profits over the same period of last year.
According to digbei.com, Xinbang pharmaceutical is mainly engaged in medical services, pharmaceutical circulation and pharmaceutical industry.